Primary prophylaxis for venous thromboembolism in ambulatory cancer patients: a systematic review and network meta-analysis
Lists
Only you see this
Abstract
Anticoagulation therapies in ambulatory cancer patients can significantly reduce the risk of VTE. However, this protective effect was associated with a significantly increased risk of major bleeding. Apixaban at the appropriate dose can decrease the risk of VTE without increasing the bleeding risk. These findings require validation in larger study cohorts.
BibTeX
@article{xin2020primary,
author = {Zechang Xin and Fei Liu and Yan Ping Du and Feiyu Mao and Xiaodong Wang and Peng Xu and Zhennan Li and Jianjun Qian and Jie Yao},
title = {{Primary prophylaxis for venous thromboembolism in ambulatory cancer patients: a systematic review and network meta-analysis}},
journal = {Annals},
year = {2020},
doi = {10.21037/apm-20-47},
}Loading related content...